MyAlgoMate
// QUARTERLY RESULTS

Aurobindo Pharma Q2 FY27 results

AUROPHARMA · Aurobindo Pharma Limited · F&O stock

Aurobindo Pharma declared its Q2 FY27 results on Wednesday, 4 November 2026; they were filed with NSE at 7:53 PM IST. As filed (consolidated): revenue from operations ₹10,263.29 crore, net profit / (loss) ₹1,123.84 crore, basic EPS ₹19.57.

Updated automatically · Last change 4 Nov 2026, 10:45 PM IST

Q2 FY27 results · declared

Wed, 4 Nov 2026

Filed with NSE at 7:53 PM IST

Revenue from operations
₹10,263.29 crore
Net profit / (loss) for the period
₹1,123.84 crore
Basic EPS (₹)
₹19.57

Consolidated, unaudited · exactly as filed by the company with NSE · view the filing ↗

Next results meeting

Not announced yet

Q3 FY27 results are due by Sun, 14 Feb 2027 — the legal deadline (45 days after the quarter ends).

A year ago, the same quarter's results meeting was on Monday, 9 February 2026.

Aurobindo Pharma quarterly results, as filed

Consolidated figures in ₹ crore (EPS in ₹), copied automatically from the company's own results data files on NSE, exactly as filed. Each quarter links to its filing.

Aurobindo Pharma quarterly results as filed with NSE
ItemQ2 FY27Q1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26
Revenue from operations10,263.299,150.358,853.348,645.98,285.77,868.14
Total income10,431.519,414.588,970.388,833.548,406.297,973.44
Profit / (loss) before tax1,690.611,516.631,293.041,338.151,274.261,204.88
Net profit / (loss) for the period1,123.841,032.03920.84909.8848.13824.2
Net profit / (loss) attributable to owners1,126.081,032.56921.26910.29848.45824.75
Basic EPS (₹)19.5717.8615.8615.6714.6114.2

Add to my calendar · free

Never miss Aurobindo Pharma's results day

Add it once — every quarter's results date for Aurobindo Pharma lands in your calendar by itself as soon as the company announces it, and moves if the company changes it.

  • Free · no sign-up
  • Every quarter, automatically
  • Google · Apple · Outlook

Follow more than one stock? Put the Nifty 50, Nifty Bank or your own pick of stocks in one calendar →

Aurobindo Pharma past results dates

Aurobindo Pharma results board meeting dates and official results filings
QuarterBoard meetingResults filed (NSE)Also considered
Q2 FY27Wed, 4 Nov 20267:53 PM · PDF ↗Dividend
Q1 FY27Wed, 5 Aug 20267:47 PM · PDF ↗—
Q4 FY26Thu, 21 May 20267:40 PM · PDF ↗—
Q3 FY26Mon, 9 Feb 20267:33 PM · PDF ↗—
Q2 FY26Wed, 5 Nov 20257:55 PM · PDF ↗—
Q1 FY26Mon, 4 Aug 20257:23 PM · PDF ↗Dividend
Q4 FY25Mon, 26 May 2025——
Q3 FY25Thu, 6 Feb 20257:51 PM · PDF ↗—
Q2 FY25Sat, 9 Nov 20246:54 PM · PDF ↗—
Q1 FY25Sat, 10 Aug 20246:29 PM · PDF ↗—
Q4 FY24Sat, 25 May 20246:55 PM · PDF ↗—
Q3 FY24Sat, 10 Feb 20245:38 PM · PDF ↗—
// FAQ

Aurobindo Pharma results: common questions

Aurobindo Pharma declared its Q2 FY27 results on Wednesday, 4 November 2026 (filed with NSE at 7:53 PM IST). As filed (consolidated, unaudited): revenue from operations ₹10,263.29 crore, net profit / (loss) ₹1,123.84 crore, basic EPS ₹19.57. The complete results are in the company's official filing, linked on this page.

Aurobindo Pharma has not announced its Q3 FY27 results date yet. Listed companies must publish these results by Sunday, 14 February 2027 (45 days after the quarter ends). A year ago, the same quarter's results meeting was on Monday, 9 February 2026. The date appears here — and in your calendar, if you subscribe below — as soon as the company informs the exchange.

Companies don't announce a time in advance — the results are filed with NSE once the board has approved them. Aurobindo Pharma's last 4 results were filed at 7:53 PM (4 Nov 2026), 7:47 PM (5 Aug 2026), 7:40 PM (21 May 2026), 7:33 PM (9 Feb 2026).

In the company's own results filing with NSE (the "Outcome of Board Meeting" filing). This page links that official PDF as soon as it is filed, and shows the main figures exactly as the company filed them.

Use "Add to my calendar" on this page. It adds a calendar of Aurobindo Pharma's results dates to Google, Apple or Outlook calendar, and each new quarter's date is added automatically once announced.

The Indian financial year runs from April to March: Q1 is April–June, Q2 July–September, Q3 October–December and Q4 January–March. "FY27" is the year ending March 2027.

Please note

This page updates itself automatically — every few hours, and about every 15 minutes on results day. Dates are the board meetings the company has announced and can change at short notice. Figures are copied from the company's own results filing with NSE, exactly as filed; always check the official filing. This page is for information only — it is not a recommendation to buy, sell or hold AUROPHARMA.

// MORE FREE TOOLS

Every results date in one place.

Share this page